Osteoporosis in German men: a cost-of-illness study. (June 2015)

• Record Type: Journal Article
• Authors: Berghaus, Sabine; Müller, Dirk; Gandjour, Afschin; Civello, Daniele; Stock, Stephanie
• Is Part Of: Expert review of pharmacoeconomics & outcomes research. Volume 15:Number 3(2015)
• Page Start: 531
• Page End: 537
• Publication Date: 2015-06
• Subjects: Pharmacology -- Economic aspects -- Periodicals; 338.47615105
• DOI: 10.1586/14737167.2015.990885
• Languages: English
• ISSNs: 1473-7167

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>Costs of male osteoporosis may have increased due to population aging and change of treatment patterns. This cost-of-illness study provides a current estimate of the economic burden of male osteoporosis in Germany. Routine claims data from six German sickness funds were analyzed and extrapolated to the German statutory health insurance (SHI). For men above the age of 50 with at least one ICD-10 osteoporosis-related diagnosis or osteoporosis-related fracture in 2010, direct costs related to osteoporosis were considered based on a payer's perspective. Total direct costs attributable to osteoporosis amounted to €728 million in 2010. The majority of these costs (71%) resulted from inpatient treatment due to fractures. Patients aged 75 and older caused approximately 63% of costs. Male osteoporosis represents a non-negligible economic burden for the German health care system. Targeted prevention and promotion measures should be offered both to men and women.</p> </abstract>